Literature DB >> 9518498

Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus.

E G Marcusson1, B Bhat, M Manoharan, C F Bennett, N M Dean.   

Abstract

Antisense oligonucleotides complementary to specific mRNA sequences are widely used inhibitors of gene expression in vitro and in vivo . In vitro cationic lipids have been demonstrated to increase the pharmacological activity of antisense oligonucleotides by increasing cellular uptake and facilitating nuclear accumulation. We have investigated the intracellular fate of oligonucleotide/cationic lipid complexes using fluorescently labeled lipids and oligonucleotides targeted to protein kinase C-alpha. After addition to cells the lipids initially co-localized with the oligonucleotide on the cell surface and in fine punctate structures within the cytoplasm. At later times the oligonucleotide began to accumulate in the nucleus as well as the cytoplasm. In contrast, the cationic lipid remained localized to the cell surface and the cytoplasm and was never found in the nucleus. Expression of protein kinase C-alpha mRNA did not begin to decline until after oligonucleotide was seen in the nucleus. This was also coincident with the transient appearance of a smaller mRNA transcript believed to result from RNase H cleavage of protein kinase C-alpha mRNA. These data suggest that although cationic lipids facilitate uptake of oligonucleotides, the complex must disassociate before the oligonucleotide can gain access to the nucleus and induce degradation of targeted mRNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518498      PMCID: PMC147486          DOI: 10.1093/nar/26.8.2016

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  56 in total

1.  Intracellular distribution of microinjected antisense oligonucleotides.

Authors:  J P Leonetti; N Mechti; G Degols; C Gagnor; B Lebleu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  Delivery of oligoribonucleotides to human hepatoma cells using cationic lipid particles conjugated to ferric protoporphyrin IX (heme).

Authors:  G B Takle; A R Thierry; S M Flynn; B Peng; L White; W Devonish; R A Galbraith; A R Goldberg; S T George
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1997-06

3.  In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells.

Authors:  M K Bijsterbosch; M Manoharan; E T Rump; R L De Vrueh; R van Veghel; K L Tivel; E A Biessen; C F Bennett; P D Cook; T J van Berkel
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

4.  Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues.

Authors:  M Butler; K Stecker; C F Bennett
Journal:  Lab Invest       Date:  1997-10       Impact factor: 5.662

5.  Rapid nuclear accumulation of injected oligodeoxyribonucleotides.

Authors:  D J Chin; G A Green; G Zon; F C Szoka; R M Straubinger
Journal:  New Biol       Date:  1990-12

6.  Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

Authors:  L A Yakubov; E A Deeva; V F Zarytova; E M Ivanova; A S Ryte; L V Yurchenko; V V Vlassov
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Characterization of oligonucleotide transport into living cells.

Authors:  S L Loke; C A Stein; X H Zhang; K Mori; M Nakanishi; C Subasinghe; J S Cohen; L M Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

8.  Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol.

Authors:  S Wang; R J Lee; G Cauchon; D G Gorenstein; P S Low
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

9.  Biosynthesis in vitro of fucose-containing glycosphingolipids in human neuroblastoma IMR-32 cells.

Authors:  K A Presper; M Basu; S Basu
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

10.  Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake.

Authors:  J P Leonetti; G Degols; B Lebleu
Journal:  Bioconjug Chem       Date:  1990 Mar-Apr       Impact factor: 4.774

View more
  28 in total

1.  Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides.

Authors:  C Pichon; M B Roufaï; M Monsigny; P Midoux
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

Review 2.  Molecular therapy in ocular wound healing.

Authors:  M F Cordeiro; G S Schultz; R R Ali; S S Bhattacharya; P T Khaw
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

Review 3.  Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.

Authors:  R L Juliano; S Alahari; H Yoo; R Kole; M Cho
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

4.  Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.

Authors:  H Yoo; R L Juliano
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

Review 5.  Preclinical and clinical pharmacology of antisense oligonucleotides.

Authors:  E G Marcusson; B R Yacyshyn; W R Shanahan; N M Dean
Journal:  Mol Biotechnol       Date:  1999-08       Impact factor: 2.695

6.  Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.

Authors:  F Shi; A Nomden; V Oberle; J B Engberts; D Hoekstra
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

Review 7.  Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.

Authors:  Peter Sazani; Ryszard Kole
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 8.  Improvement of DNA transfection with cationic liposomes.

Authors:  A Rocha; S Ruiz; J M Coll
Journal:  J Physiol Biochem       Date:  2002-03       Impact factor: 4.158

9.  LNA-based oligonucleotide electrotransfer for miRNA inhibition.

Authors:  Sophie Chabot; Julie Orio; Romain Castanier; Elisabeth Bellard; Søren J Nielsen; Muriel Golzio; Justin Teissié
Journal:  Mol Ther       Date:  2012-05-22       Impact factor: 11.454

10.  Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.

Authors:  Qiang Hu; Marcel B Bally; Thomas D Madden
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.